New Coronaviruses are retroviruses. The term retrovirus generally refers to RNA viruses. With the help of reverse transcriptase enzyme, it is reverse transcribed into DNA, which is then integrated into the DNA of the infected person and replicates, gaining the ability of the virus to persist. The new coronavirus belongs to this type, and its replication process is consistent with the replication process of reverse transcription viruses, where the virus acquires the ability to continue replicating and constantly infects new cells causing inflammatory symptoms. Because of this characteristic of the virus, there are some drug developments that may target the reverse transcription process of the virus, such as the development of drugs to inhibit the activity of the reverse transcriptase enzyme, in the hope that this will lead to the treatment of neocoronavirus pneumonia.